Polymorphisms of the Flavin containing monooxygenase 3 (FMO3) gene do not predispose to essential hypertension in Caucasians -: art. no. 41

被引:15
作者
Dolan, C
Shields, DC
Stanton, A
O'Brien, E
Lambert, DM
O'Brien, JK
Treacy, EP
机构
[1] Childrens Univ Hosp, Natl Ctr Inherited Metab Disorders, Dublin 1, Ireland
[2] Royal Coll Surgeons Ireland, Dept Clin Pharmacol, Dublin 2, Ireland
[3] Natl Univ Ireland Univ Coll Dublin, Conway Inst, Dublin 4, Ireland
[4] Beaumont Hosp, ADAPT Ctr, Dublin 2, Ireland
[5] Childrens Univ Hosp, Dept Genet, Dublin 1, Ireland
关键词
D O I
10.1186/1471-2350-6-41
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学]; 090102 [作物遗传育种];
摘要
Background: The recessive disorder trimethylaminuria is caused by defects in the FMO3 gene, and may be associated with hypertension. We investigated whether common polymorphisms of the FMO3 gene confer an increased risk for elevated blood pressure and/or essential hypertension. Methods: FMO3 genotypes (EI58K, V257M, E308G) were determined in 387 healthy subjects with ambulatory systolic and diastolic blood pressure measurements, and in a cardiovascular disease population of 1649 individuals, 691(41.9%) of whom had a history of hypertension requiring drug treatment. Haplotypes were determined and their distribution noted. Results: There was no statistically significant association found between any of the 4 common haplotypes and daytime systolic blood pressure in the healthy population (p = 0.65). Neither was a statistically significant association found between the 4 common haplotypes and hypertension status among the cardiovascular disease patients (p = 0.80). Conclusion: These results suggest that the variants in the FMO3 gene do not predispose to essential hypertension in this population.
引用
收藏
页数:7
相关论文
共 35 条
[1]
Akerman BR, 1999, HUM MUTAT, V13, P376, DOI 10.1002/(SICI)1098-1004(1999)13:5<376::AID-HUMU5>3.0.CO
[2]
2-A
[3]
Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort [J].
Akerman, BR ;
Lemass, H ;
Chow, LML ;
Lambert, DM ;
Greenberg, C ;
Bibeau, C ;
Mamer, OA ;
Treacy, EP .
MOLECULAR GENETICS AND METABOLISM, 1999, 68 (01) :24-31
[4]
Survival in treated hypertension: follow up study after two decades [J].
Andersson, OK ;
Almgren, T ;
Persson, B ;
Samuelsson, O ;
Hedner, T ;
Wilhelmsen, L .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 317 (7152) :167-171
[5]
PREVALENCE OF HYPERTENSION IN THE US ADULT-POPULATION - RESULTS FROM THE 3RD NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEY, 1988-1991 [J].
BURT, VL ;
WHELTON, P ;
ROCCELLA, EJ ;
BROWN, C ;
CUTLER, JA ;
HIGGINS, M ;
HORAN, MJ ;
LABARTHE, D .
HYPERTENSION, 1995, 25 (03) :305-313
[6]
Cashman JR, 2000, DRUG METAB DISPOS, V28, P169
[7]
Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria [J].
Cashman, JR ;
Bi, YA ;
Lin, J ;
Youil, R ;
Knight, M ;
Forrest, S ;
Treacy, E .
CHEMICAL RESEARCH IN TOXICOLOGY, 1997, 10 (08) :837-841
[8]
Creagh D, 2002, Ir Med J, V95, P298
[9]
Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome [J].
Dolphin, CT ;
Janmohamed, A ;
Smith, RL ;
Shephard, EA ;
Phillips, IR .
NATURE GENETICS, 1997, 17 (04) :491-494
[10]
POTENTIAL ROLE OF THE FLAVIN-CONTAINING MONOOXYGENASES IN THE METABOLISM OF ENDOGENOUS COMPOUNDS [J].
ELFARRA, AA .
CHEMICO-BIOLOGICAL INTERACTIONS, 1995, 96 (01) :47-55